<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Pretreatment of aorta with potassium channels blockers; TEA (98.91% ± 3, 73; 
 <italic class="italic">p</italic> &gt; 0.05), 4-AP (98.05% ± 2.96; 
 <italic class="italic">p</italic> &gt; 0.05), BaCl
 <sub class="sub">2</sub> (103.52% ± 2.47; p &gt; 0.05) and glybenclamide (99.55% ± 2.66; 
 <italic class="italic">p</italic> &gt; 0.05), showed no significant changes in AcEO (0.1–100 μg/ml) induced-vasorelaxation (Fig. 
 <xref rid="Fig6" ref-type="fig" class="xref">6a</xref>). 
</p>
